Total Payments
$380,161
2024 Payments
$163,954
Companies
59
Transactions
1,091
Medicare Patients
12,213
Medicare Billing
$1.3M
Payment Breakdown by Category
Other$318,165 (83.7%)
Travel$29,277 (7.7%)
Food & Beverage$25,846 (6.8%)
Education$5,837 (1.5%)
Research$1,036 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $317,290 | 148 | 83.5% |
| Travel and Lodging | $29,277 | 94 | 7.7% |
| Food and Beverage | $25,846 | 823 | 6.8% |
| Education | $5,837 | 16 | 1.5% |
| Unspecified | $1,036 | 9 | 0.3% |
| Honoraria | $875.00 | 1 | 0.2% |
Payments by Type
General
$379,125
1,082 transactions
Research
$1,036
9 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $296,757 | 356 | $0 (2024) |
| GlaxoSmithKline, LLC. | $37,170 | 138 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15,350 | 78 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $6,867 | 27 | $0 (2024) |
| INTUITIVE SURGICAL, INC. | $6,749 | 9 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $2,803 | 5 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $2,153 | 100 | $0 (2024) |
| Inspire Medical Systems, Inc. | $1,955 | 48 | $0 (2024) |
| Grifols USA, LLC | $1,080 | 35 | $0 (2024) |
| Boston Scientific Corporation | $988.56 | 15 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $163,954 | 272 | AstraZeneca Pharmaceuticals LP ($153,771) |
| 2023 | $90,847 | 113 | AstraZeneca Pharmaceuticals LP ($90,105) |
| 2022 | $25,017 | 70 | AstraZeneca Pharmaceuticals LP ($17,884) |
| 2021 | $28,075 | 66 | AstraZeneca Pharmaceuticals LP ($17,041) |
| 2020 | $19,497 | 79 | GlaxoSmithKline, LLC. ($13,134) |
| 2019 | $16,641 | 126 | AstraZeneca Pharmaceuticals LP ($7,102) |
| 2018 | $24,548 | 201 | AstraZeneca Pharmaceuticals LP ($7,823) |
| 2017 | $11,581 | 164 | Boehringer Ingelheim Pharmaceuticals, Inc. ($7,461) |
All Payment Transactions
1,091 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $4.67 | General |
| Category: NEUROLOGY | ||||||
| 12/18/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $2.32 | General |
| Category: NEUROLOGY | ||||||
| 12/16/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 12/16/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $10.05 | General |
| Category: NEUROLOGY | ||||||
| 12/12/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: NEUROLOGY | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $3.50 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $19.05 | General |
| Category: HFCWO | ||||||
| 12/10/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: NEUROLOGY | ||||||
| 12/06/2024 | Grifols USA, LLC | Xembify (Biological) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: Immunology and Neurology | ||||||
| 12/04/2024 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $23.01 | General |
| Category: Allergy/Immunology | ||||||
| 12/03/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: IMMUNOLOGY | ||||||
| 12/01/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,700.00 | General |
| Category: Respiratory | ||||||
| 11/27/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,250.00 | General |
| Category: Respiratory | ||||||
| 11/22/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: NEUROLOGY | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,400.00 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | Vifor Pharma, Inc. | Zemaira (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $28.99 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $2.64 | General |
| Category: NEUROLOGY | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Travel and Lodging | In-kind items and services | $147.26 | General |
| Category: Respiratory | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Travel and Lodging | In-kind items and services | $557.80 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Travel and Lodging | In-kind items and services | $534.88 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 3,185 | 5,088 | $1.6M | $360,815 |
| 2022 | 32 | 3,763 | 5,757 | $1.8M | $433,776 |
| 2021 | 33 | 3,040 | 4,120 | $1.1M | $348,876 |
| 2020 | 18 | 2,225 | 2,810 | $513,671 | $196,535 |
Total Patients
12,213
Total Services
17,775
Medicare Billing
$1.3M
Procedure Codes
108
All Medicare Procedures & Services
108 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 292 | 995 | $447,417 | $90,239 | 20.2% |
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 237 | 608 | $388,620 | $79,545 | 20.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 419 | 710 | $202,854 | $58,385 | 28.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 88 | 102 | $101,805 | $21,418 | 21.0% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 207 | 401 | $118,573 | $20,566 | 17.3% |
| 99345 | Residence visit for new patient with high level of medical decision making, per day, if using time, at least 75 minutes | Office | 2023 | 123 | 123 | $92,937 | $16,927 | 18.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 136 | 136 | $53,256 | $16,276 | 30.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 335 | 348 | $46,018 | $13,806 | 30.0% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 337 | 350 | $44,338 | $13,433 | 30.3% |
| 99344 | Residence visit for new patient with moderate level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 73 | 73 | $45,242 | $7,371 | 16.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 258 | 267 | $17,478 | $5,189 | 29.7% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 20 | 20 | $13,195 | $3,070 | 23.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 20 | 20 | $12,000 | $3,020 | 25.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 86 | 88 | $8,484 | $2,279 | 26.9% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 45 | 47 | $16,450 | $1,906 | 11.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 249 | 505 | $7,575 | $1,621 | 21.4% |
| 99347 | Residence visit for established patient with straightforward medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 29 | 41 | $7,968 | $1,372 | 17.2% |
| 99449 | Telephone or internet assessment with verbal and written report by consulting physician, more than 30 minutes | Office | 2023 | 20 | 20 | $2,800 | $1,041 | 37.2% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 45 | 48 | $3,600 | $981.69 | 27.3% |
| 99448 | Telephone or internet assessment with verbal and written report by consulting physician, 21-30 minutes | Office | 2023 | 18 | 18 | $1,908 | $742.86 | 38.9% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 25 | 26 | $2,103 | $668.72 | 31.8% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 11 | 13 | $920.00 | $622.96 | 67.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 87 | 95 | $1,425 | $323.95 | 22.7% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 14 | 21 | $1,085 | $8.43 | 0.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 11 | 13 | $65.00 | $1.10 | 1.7% |
About Dr. David Marks, M.D
Dr. David Marks, M.D is a Pulmonary Disease healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821016023.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Marks, M.D has received a total of $380,161 in payments from pharmaceutical and medical device companies, with $163,954 received in 2024. These payments were reported across 1,091 transactions from 59 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($317,290).
As a Medicare-enrolled provider, Marks has provided services to 12,213 Medicare beneficiaries, totaling 17,775 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 108 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location San Antonio, TX
- Active Since 07/17/2006
- Last Updated 10/20/2014
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1821016023
Products in Payments
- BREZTRI (Drug) $178,603
- AIRSUPRA (Drug) $99,658
- TRELEGY ELLIPTA (Drug) $34,994
- Adempas (Drug) $6,867
- Da Vinci Surgical System (Device) $6,749
- DALIRESP (Drug) $5,521
- SYMBICORT (Drug) $4,907
- BEVESPI AEROSPHERE (Drug) $4,539
- ACTHAR (Biological) $2,964
- BREZTRI AEROSPHERE (Drug) $2,245
- INSPIRE (Device) $1,955
- OFEV (Drug) $900.60
- The Vest System 205 Acute Care (Device) $890.36
- Pulmonx Endobronchial Valve EBV (Device) $844.87
- UPTRAVI (Drug) $793.81
- GLASSIA (Biological) $764.37
- Prolastin-C (Biological) $679.33
- OPSUMIT MACITENTAN (Drug) $639.08
- DUPIXENT (Biological) $487.25
- NUCALA (Biological) $478.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in San Antonio
Antonio Anzueto, Md, MD
Pulmonary Disease — Payments: $2.0M
Pulmonary Disease $2.0M
Dr. Diego Maselli Caceres, M.d, M.D
Pulmonary Disease — Payments: $1.4M
Pulmonary Disease $1.4M
Charles Andrews, M.d, M.D
Pulmonary Disease — Payments: $295,102
Pulmonary Disease $295,102
Napoleon Puente Cuellar, M.d, M.D
Pulmonary Disease — Payments: $185,010
Pulmonary Disease $185,010
Dr. Anoop Nambiar, M.d, M.D
Pulmonary Disease — Payments: $152,462
Pulmonary Disease $152,462
Soma Jyothula, Md, MD
Pulmonary Disease — Payments: $133,953
Pulmonary Disease $133,953